Health & Nutrition

bg
Why Is Sorghum One of My New Favorite Grains? 

Why Is Sorghum One of My New Favorite Grains? 

Learn why sorghum is one of my favorite new grains. “Despite playing a significant...

bg
GE Healthcare soars 9% on earnings beat, wise guidance. Here's our new price target

GE Healthcare soars 9% on earnings beat, wise guidance....

We're lifting our price target on the medical technology provider after an encouraging...

bg
U.S. investors, Big Pharma race to find new medicines in China

U.S. investors, Big Pharma race to find new medicines in...

U.S. investors and large pharmaceutical companies are increasingly doing deals in...

bg
Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding

Prenuvo adds new health tests to flagship full-body scan,...

Prenuvo exploded in popularity because of its $2,500 full-body MRI scan that has...

bg
Moderna beats on revenue but loses more than expected as it scales down manufacturing

Moderna beats on revenue but loses more than expected as...

It marks another quarter of growing pains for the company, which is racing to launch...

bg
CVS shares are up 45% this year — here's why it may be starting to turn its business around

CVS shares are up 45% this year — here's why it may be...

Some analysts are more optimistic about CVS' ability to navigate higher-than-expected...

bg
Is Sorghum a Healthy Grain? 

Is Sorghum a Healthy Grain? 

How does sorghum compare with other grains in terms of protein, antioxidants, and...

bg
We're adding to our position in a sliding stock and booking profits in a 2025 winner

We're adding to our position in a sliding stock and booking...

We're making a pair of trades Monday as Wall Street rallies to kick off the week.

bg
Ozempic (Semaglutide) and Other GLP-1 Weight-Loss Drugs: Their Uses, Side Effects, and More

Ozempic (Semaglutide) and Other GLP-1 Weight-Loss Drugs:...

Ozempic and others in a new class of weight-loss drugs have been called “the medical...

bg
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

Trump is unlikely to end Medicare drug price talks — here's...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical...